Argonaut Manufacturing Services is an FDA-registered contract development and manufacturing organization serving biopharma, life sciences, and molecular diagnostics customers. Its core capabilities include aseptic vial filling, automated high-yield sterile injectable filling, and diagnostic lyophilization and kitting. The company holds ISO 13485:2016 certification for drug-device combination products and its quality systems have been audited by the FDA and PMDA. Argonaut is expanding drug product fill/finish capacity with a new dedicated isolator-based filling line in Carlsbad, CA that more than quadruples existing capacity and adds pre-fill syringe and cartridge capability. The expansion has been underway since early 2023 and Argonaut expects to have the facility and equipment fully validated in 2025. To support this build-out the company completed a financing to fund the capacity expansion and continue serving clinical and commercial supply needs. Argonaut Manufacturing Services is a contract manufacturer for biotech companies based in Carlsbad, CA. The company produces molecular diagnostic and life science reagents and consumables and supports all product stages from launch to revitalization. Its services include project planning, supplier management and global logistics. Clients receive products compliant with applicable regulations and savings realized through cost variabilization. The company is led by CEO Wayne Woodard and is backed by venture capital firm Telegraph Hill Partners. Argonaut recently obtained financing intended to support capital expenditures.

Total raised

$50M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2024